HDAC9 is overexpressed in neurons during stroke and exerts neurotoxic effects by inhibiting autophagy, activating inhibitor kappa B alpha /nuclear factor kappaB (IB/NFb) and mitogenactivated protein kinases (MAPKs) signaling pathways, and reducing the expression of miR20a, upregulating its target gene Neurod1 [87, 88, 89]
Retrieved 2012-02-10
GLP-1 achieves the decrease in blood glucose levels by potentiating glucose-induced insulin secretion (the incretin-effect), improving insulin sensitivity and inhibiting glucagon release
Ozempic: "Ozempic - Semaglutide." Accessed on December 5, 2023, at "GLP-1 Receptor Agonists and Their Evolving Role in the Management of Obesity." National Library of Medicine
PubMed Sokol RJ, Johnson KE, Karrer FM, et al
GLP-1 drugs work in your body by: Stimulating insulin secretion from beta cells in the pancreas when blood sugar is high, which helps lower blood sugar levels